These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35400024)

  • 1. High-choline diets ameliorate acute graft-versus-host disease.
    Hu B; Wu D; Xu Y
    Blood Sci; 2020 Oct; 2(4):146-147. PubMed ID: 35400024
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucocorticoids delivered by inorganic-organic hybrid nanoparticles mitigate acute graft-versus-host disease and sustain graft-versus-leukemia activity.
    Kaiser TK; Li H; Roßmann L; Reichardt SD; Bohnenberger H; Feldmann C; Reichardt HM
    Eur J Immunol; 2020 Aug; 50(8):1220-1233. PubMed ID: 32133644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
    Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
    Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel chicken model of fatty liver disease induced by high cholesterol and low choline diets.
    Lin CW; Huang TW; Peng YJ; Lin YY; Mersmann HJ; Ding ST
    Poult Sci; 2021 Mar; 100(3):100869. PubMed ID: 33516481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models.
    Mashima K; Oh I; Fujiwara K; Izawa J; Takayama N; Nakano H; Kawasaki Y; Minakata D; Yamasaki R; Morita K; Ashizawa M; Yamamoto C; Hatano K; Sato K; Ohmine K; Fujiwara SI; Ohno N; Kanda Y
    PLoS One; 2021; 16(1):e0245232. PubMed ID: 33428661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of norepinephrine and expression levels of ß2-adrenergic receptor gene correlate with the incidence of acute graft-versus-host disease.
    Momeni-Varposhti Z; Kazemi MH; Talebi M; Chegeni R; Roshandel E; Hajifathali A; Movassaghpour AA
    Med J Islam Repub Iran; 2020; 34():151. PubMed ID: 33437747
    [No Abstract]   [Full Text] [Related]  

  • 7. Upper gastrointestinal acute graft-
    Nikiforow S; Wang T; Hemmer M; Spellman S; Akpek G; Antin JH; Choi SW; Inamoto Y; Khoury HJ; MacMillan M; Marks DI; Meehan K; Nakasone H; Nishihori T; Olsson R; Paczesny S; Przepiorka D; Reddy V; Reshef R; Schoemans H; Waller N; Weisdorf D; Wirk B; Horowitz M; Alousi A; Couriel D; Pidala J; Arora M; Cutler C;
    Haematologica; 2018 Oct; 103(10):1708-1719. PubMed ID: 30076185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival after acute graft-
    Khoury HJ; Wang T; Hemmer MT; Couriel D; Alousi A; Cutler C; Aljurf M; Antin JH; Ayas M; Battiwalla M; Cahn JY; Cairo M; Chen YB; Gale RP; Hashmi S; Hayashi RJ; Jagasia M; Juckett M; Kamble RT; Kharfan-Dabaja M; Litzow M; Majhail N; Miller A; Nishihori T; Qayed M; Schoemans H; Schouten HC; Socie G; Storek J; Verdonck L; Vij R; Wood WA; Yu L; Martino R; Carabasi M; Dandoy C; Gergis U; Hematti P; Solh M; Jamani K; Lehmann L; Savani B; Schultz KR; Wirk BM; Spellman S; Arora M; Pidala J
    Haematologica; 2017 May; 102(5):958-966. PubMed ID: 28302712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell transplantation.
    Eefting M; von dem Borne PA; de Wreede LC; Halkes CJ; Kersting S; Marijt EW; Veelken H; Falkenburg JF
    Haematologica; 2014 Apr; 99(4):751-8. PubMed ID: 24241493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Minnesota acute graft-
    MacMillan ML; DeFor TE; Holtan SG; Rashidi A; Blazar BR; Weisdorf DJ
    Haematologica; 2020; 105(2):519-524. PubMed ID: 31320554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids.
    Pidala J; Tomblyn M; Nishihori T; Field T; Ayala E; Perkins J; Fernandez H; Locke F; Perez L; Ochoa JL; Alsina M; Anasetti C
    Haematologica; 2011 Sep; 96(9):1351-6. PubMed ID: 21565902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Nakamura H; Komatsu K; Ayaki M; Kawamoto S; Murakami M; Uoshima N; Yagi T; Hasegawa T; Yasumi M; Karasuno T; Teshima H; Hiraoka A; Masaoka T
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 2):S45-50. PubMed ID: 10887333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dietary lipid manipulation upon graft vs host and host vs graft responses in the rat.
    Sanderson P; Yaqoob P; Calder PC
    Cell Immunol; 1995 Sep; 164(2):240-7. PubMed ID: 7656333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT features with pathologic correlation of acute gastrointestinal graft-versus-host disease after bone marrow transplantation in adults.
    Kalantari BN; Mortelé KJ; Cantisani V; Ondategui S; Glickman JN; Gogate A; Ros PR; Silverman SG
    AJR Am J Roentgenol; 2003 Dec; 181(6):1621-5. PubMed ID: 14627585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human graft-versus-host disease.
    Parkman R
    Immunodefic Rev; 1991; 2(4):253-64. PubMed ID: 2059433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study.
    Escamilla Gómez V; García-Gutiérrez V; López Corral L; García Cadenas I; Pérez Martínez A; Márquez Malaver FJ; Caballero-Velázquez T; González Sierra PA; Viguria Alegría MC; Parra Salinas IM; Calderón Cabrera C; González Vicent M; Rodríguez Torres N; Parody Porras R; Ferra Coll C; Orti G; Valcárcel Ferreiras D; De la Cámara LLanzá R; Molés P; Velázquez-Kennedy K; João Mende M; Caballero Barrigón D; Pérez E; Martino Bofarull R; Saavedra Gerosa S; Sierra J; Poch M; Zudaire Ripa MT; Díaz Pérez MA; Molina Angulo B; Sánchez Ortega I; Sanz Caballer J; Montoro Gómez J; Espigado Tocino I; Pérez-Simón JA;
    Bone Marrow Transplant; 2020 Mar; 55(3):641-648. PubMed ID: 31700138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human graft versus host disease.
    Parkman R; Rappeport J; Rosen F
    J Invest Dermatol; 1980 May; 74(5):276-9. PubMed ID: 6993570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease.
    Laverdière I; Guillemette C; Tamouza R; Loiseau P; Peffault de Latour R; Robin M; Couture F; Filion A; Lalancette M; Tourancheau A; Charron D; Socié G; Lévesque É
    Haematologica; 2015 Feb; 100(2):275-83. PubMed ID: 25425682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma.
    Anasetti C; Beatty PG; Storb R; Martin PJ; Mori M; Sanders JE; Thomas ED; Hansen JA
    Hum Immunol; 1990 Oct; 29(2):79-91. PubMed ID: 2249952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft-versus-host disease.
    Cuzzola M; Fiasché M; Iacopino P; Messina G; Martino M; Console G; Fedele R; Massi D; Recchia AG; Irrera G; Morabito F
    Haematologica; 2012 Oct; 97(10):1532-8. PubMed ID: 22491736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.